Citadel Advisors - MEDICAL TRANSCRIPTION BLG CO ownership

MEDICAL TRANSCRIPTION BLG CO's ticker is MTBC and the CUSIP is 58464J105. A total of 12 filers reported holding MEDICAL TRANSCRIPTION BLG CO in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of MEDICAL TRANSCRIPTION BLG CO
ValueSharesWeighting
Q3 2017$28,000
+75.0%
18,922
-20.1%
0.00%
Q1 2017$16,000
-46.7%
23,694
-25.4%
0.00%
Q3 2016$30,000
+100.0%
31,779
+78.7%
0.00%
Q2 2016$15,000
-21.1%
17,785
-5.6%
0.00%
Q1 2016$19,00018,8460.00%
Other shareholders
MEDICAL TRANSCRIPTION BLG CO shareholders Q4 2017
NameSharesValueWeighting ↓
BURNS J W & CO INC/NY 14,158$37,0000.01%
QCI ASSET MANAGEMENT INC/NY 19,158$50,0000.01%
Virtu Financial LLC 10,825$28,0000.00%
PANAGORA ASSET MANAGEMENT INC 26,784$70,0000.00%
MORGAN STANLEY 250$1,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 12,514$33,0000.00%
VANGUARD GROUP INC 91,380$238,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 750$2,0000.00%
UBS Group AG 3,096$8,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 30,694$80,0000.00%
View complete list of MEDICAL TRANSCRIPTION BLG CO shareholders